PREVEXXION® RN
The Future is Now
Details
PREVEXXION® RN is a biological tool effective against very virulent strains of Marek’s disease (MD). The vaccine contains a frozen Marek’s disease chimera consisting of three serotype1 strains. Since Marek’s disease maintains a constant pressure on farms, keeping the disease under control through vaccination is critical.1
Key Advantages
-
Innovative attenuation process delivers the right balance between safety3 & efficacy3
-
Provides protection against very virulent MD virus
Features & Benefits
- Unprecedented and controlled attenuation process for a Marek’s disease strain that results from different MD virus and LTR gene sequence insertions
- Administration in ovo or at day-old
- Compatible with other Marek’s disease vaccines for a customized vaccination program
- Same convenient application as classic Marek's disease vaccines
- No reversion to virulence4
Dosage & Administration
- Packaged in 5 x 2,000 dose ampules in frozen presentation
Resources
Safety
- Do not vaccinate diseased embryonated eggs or birds
- Administer a full dose to each embryonated egg or to each bird
- Vaccinate all birds on the premises at one time
- Avoid stress conditions during and following vaccination
- Do not place chickens in contaminated facilities
- Exposure to disease must be minimized as much as possible
Safety Data Sheet
1Gimeno IM. Marek’s disease vaccines: a solution for today but a worry for tomorrow? Vaccine, 2008 July 18;26 Suppl 3:C31-C41.
2Witter R.L. & al., 1997, Avian Diseases, 41, p407-421.
3Morrow C., Fehler F. 2004, Marek’s disease: A worldwide problem, p49–61 in Davison F, Nair V. Elsevier, London, United Kingdom.
4Witter R.L. & al., Induction of Strong Protection by Vaccination with Partially Attenuated Serotype 1 Marek’s Disease Viruses, 2002, Avian Diseases, 46(4): p925-937.
PREVEXXION® is a trademark of Boehringer Ingelheim Animal Health USA Inc. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-POU-0062-2022